In this study, we confirmed that the level of mortalin was elevated in plasma-derived exosomes of patients with different types of tumors, which supports the premise that increased expression of mortalin may promote human carcinogenesis, with the possible exception of pancreatic carcinoma. This evidence concerns the gene HSPA9 and exocrine pancreatic carcinoma.